Roger Barker (Former)
31 – 40 of 130
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Strategies for bringing stem cell-derived dopamine neurons to the clinic : A European approach (STEM-PD)
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways
(
- Contribution to journal › Article
-
Mark
GFORCE-PD still going strong in 2016
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015
(
- Contribution to journal › Article
-
Mark
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
(
- Contribution to journal › Article
-
Mark
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells
(
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article